4//SEC Filing
Emergent BioSolutions Inc. 4
Accession 0001140361-15-011531
$EBSCIK 0001367644operating
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:01 PM ET
Size
8.8 KB
Accession
0001140361-15-011531
Insider Transaction Report
Form 4
Labinger Barry
EVP, Biosciences Div.
Transactions
- Award
Common Stock
2015-03-10+10,762→ 38,387 total - Tax Payment
Common Stock
2015-03-10$29.00/sh−1,594$46,226→ 36,793 total - Award
Employee Stock Option (right to buy)
2015-03-10+21,517→ 21,517 totalExercise: $28.99Exp: 2022-03-09→ Common Stock (21,517 underlying)
Footnotes (3)
- [F1]Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- [F2]These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- [F3]Vests in three equal installments on March 9, 2016, March 9, 2017 and March 9, 2018.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001367644
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:01 PM ET
- Size
- 8.8 KB